Worth reading
35Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Avoiding a definitive answer
How definitive the wording is.This transaction
Dissolution (special liquidation) of a consolidated subsidiaryDisclosing companyGMO Pepabo,Inc.
TimelineThe spacing between the points is proportional to the actual number of days.
Target company
Management of group companies and related activities
Location Shibuya, TokyoShare capital — thousand yen (as of the end of December 2025)Date of incorporation January 2025
Net Sales— thousand yen (fiscal year ended December 2025)
Operating profit¥37 thousand operating loss (fiscal year ended December 2025)
Net income for the current fiscal year¥1,417,214 thousand negative net assets (fiscal year ended December 2025)
Net assets¥1,417,214 thousand negative net assets (fiscal year ended December 2025)
Impact on Business Performance
The impact of this matter on consolidated results for the fiscal year ending December 2026 is currently under review. The Company will promptly announce any revisions to its earnings forecast or other actions if necessary.
Procedures and assumptions
Conditions Precedent to ExecutionApproval of the dissolution at CN's extraordinary general meeting of shareholders (scheduled for 29 June 2026)
| Item | Details |
|---|---|
| Transaction name | Dissolution (special liquidation) of a consolidated subsidiary |
| Name of the Subject Company | CN株式会社 |
| Business Description of the Subject Company | Management of group companies and related activities |
| Location of the Subject Company | Shibuya, Tokyo |
| Capital Stock of the Subject Company | — thousand yen (as of the end of December 2025) |
| Date of Establishment of the Subject Company | January 2025 |
| Net Sales of the Subject Company | — thousand yen (fiscal year ended December 2025) |
| Operating Profit of the Subject Company | ¥37 thousand operating loss (fiscal year ended December 2025) |
| Net Income of the Subject Company | ¥1,417,214 thousand negative net assets (fiscal year ended December 2025) |
| Net Assets of the Subject Company | ¥1,417,214 thousand negative net assets (fiscal year ended December 2025) |
| Voting rights ownership percentage | Before 76.6% (after not disclosed) |
| Impact on Business Performance | The impact of this matter on consolidated results for the fiscal year ending December 2026 is currently under review. The Company will promptly announce any revisions to its earnings forecast or other actions if necessary. |
| Date of board resolution | 15 June 2026 |
| Execution Date / Effective Date | Completion of special liquidation: late December 2026 (scheduled) |
| Conditions Precedent to Execution | Approval of the dissolution at CN's extraordinary general meeting of shareholders (scheduled for 29 June 2026) |
Items this document does not state (17)
Counterparty nameAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Contract DateValuation methodologyIndependent valuation institutionSpecial CommitteeManagement structure after acquisition
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.CN was established to manage GMOクリエイターズネットワーク株式会社 and for related purposes. As the transfer of the shares in that company has been completed, CN will be dissolved and liquidated.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.